US Capnography Devices Market 2026-2035

Description

List of Tables

US Capnography Devices Market Size, Share & Trends Analysis Report by Product Type (Handheld, Standalone, Multiparameter, and Others), By Application (Respiratory Disease, Cardiology, Trauma & Emergency, and Others), By End-User (Hospital & Clinics and Ambulatory Surgical Centers) Forecast Period, (2026-2035)

Industry Overview

US capnography devices market was valued at $183.5 million in 2025 and is projected to reach $277.9 million by 2035, growing at a CAGR of 4.3% during the forecast period (2026-2035). The US Capnography Devices Market is expanding as healthcare providers and hospitals increasingly prioritize patient safety and real-time respiratory monitoring. Growth is being driven by the rising adoption of advanced capnography technologies, including handheld, standalone, and multiparameter devices, which enable continuous monitoring in critical care, surgical, and emergency settings. Demand is further supported by the increasing prevalence of respiratory diseases, growing awareness of perioperative complications, and the need for early detection of ventilatory abnormalities. Integration with electronic health records and AI-powered analytics is enhancing predictive monitoring capabilities, while regulatory emphasis on patient safety standards is reinforcing the importance of reliable capnography solutions in reducing adverse events and improving clinical outcomes.

Market Dynamics

Rising Adoption of Advanced Capnography Technologies Across US Healthcare Facilities

The US capnography devices market is expanding as hospitals, ambulatory surgery centers, and critical care units increasingly adopt real-time respiratory monitoring solutions. Healthcare providers are implementing sophisticated devices ranging from handheld and standalone monitors to multiparameter systems that improve patient safety during surgery, emergency care, and chronic respiratory disease management. This shift allows clinicians to track ventilatory status more accurately, respond promptly to respiratory complications, and manage large volumes of patient data efficiently. Strategic partnerships between device manufacturers, software developers, and healthcare institutions are further driving the deployment of interoperable, cloud-enabled monitoring platforms, reflecting the US's focus on modernizing patient care through technology.

Growing Emphasis on AI-Enabled Analytics and Predictive Monitoring

AI and advanced analytics are increasingly integrated into capnography devices, enhancing predictive capabilities for early detection of respiratory distress and perioperative complications. Both leading medical device companies and innovative startups are collaborating to develop solutions that optimize monitoring workflows, reduce adverse events, and improve clinical decision-making. Additionally, federal healthcare initiatives and regulatory emphasis on patient safety are encouraging the adoption of evidence-based monitoring technologies. Collectively, these dynamics underscore the US's commitment to leveraging data-driven respiratory monitoring solutions to enhance clinical outcomes and operational efficiency.

Market Segmentation

Based on the product type, the market is segmented into handheld, standalone, multiparameter, and others.
Based on the application, the market is segmented into respiratory disease, cardiology, trauma & emergency, and others.
Based on the end-user, the market is segmented into hospital & clinics and ambulatory surgical centers.

Handheld Segment to Lead the US Market with the Largest Share

The handheld segment is poised to remain the leading component of the US capnography devices market, fuelled by high demand for portable, easy-to-use monitoring solutions across hospitals, emergency medical services (EMS), and home care settings. US healthcare providers increasingly rely on handheld capnography devices for rapid and accurate CO2 assessment during emergency interventions, patient transport, and bedside monitoring. The segment's prominence is further reinforced by innovations in compact sensor technology, longer-lasting batteries, wireless connectivity, and enhanced measurement accuracy. Rising prevalence of chronic respiratory conditions, growing emphasis on quick respiratory assessment in prehospital and outpatient care, and the expansion of remote and home-based respiratory monitoring programs are supporting strong adoption in the region.

Hospitals & Clinics: The Core Demand Centre for Capnography in the US

Hospitals and clinics remain the primary growth engine of the US capnography devices market, reflecting their critical dependence on continuous CO2 monitoring across anesthesia, intensive care, emergency medicine, and procedural sedation. Capnography is increasingly integrated into perioperative and critical care workflows, driven by stringent patient safety standards and adherence to guidelines set by organizations such as the American Society of Anesthesiologists (ASA). Rising surgical volumes, higher ICU admissions, and the growing need for advanced ventilatory management are sustaining steady demand for standalone, multiparameter, and handheld capnography systems across the country.

Market Players Outlook

The major companies operating in the US capnography devices market include GE HealthCare Technologies, Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, and Nihon Kohden Corporation, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

In September 2025, Masimo Corporation launched its updated Rad-97(TM) Pulse CO-Oximeter with integrated handheld capnography functionality, featuring enhanced wireless connectivity and cloud-based patient data analytics. The launch highlights growing demand for portable, connected respiratory monitoring solutions across US hospitals and EMS services.
In August 2025, Medtronic announced a strategic partnership with a leading AI healthcare startup to integrate predictive analytics into its multiparameter capnography systems. The collaboration aims to improve early detection of respiratory complications in critical care patients, reflecting increased investment in AI-enabled patient monitoring technologies.

The Report Covers:

Market value data analysis of 2025 and forecast to 2035.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the US capnography devices market. Based on the availability of data, information related to new products and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2023303

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
US Capnography Devices Market Sales Analysis - Product Type | Application | End-User ($ Million)
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach
1.2. Market Snapshot

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Capnography Devices Industry Trends
- 2.2.2. Market Recommendations

3. Market Determinants

3.1. Market Drivers
- 3.1.1. Drivers For US Capnography Devices Market: Impact Analysis
3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For US Capnography Devices Market: Impact Analysis
3.3. Market Opportunities
- 3.3.1. Opportunities For US Capnography Devices Market: Impact Analysis

4. Competitive Landscape

4.1. Competitive Dashboard - US Capnography Devices Market Revenue and Share by Manufacturers
Capnography Devices Product Comparison Analysis
4.2. Key Company Analysis
- 4.2.1. GE HealthCare Technologies, Inc.
  - 4.2.1.1. Overview
  - 4.2.1.2. Product Portfolio
  - 4.2.1.3. Financial Analysis
  - 4.2.1.4. SWOT Analysis
  - 4.2.1.5. Business Strategy
- 4.2.2. Koninklijke Philips N.V.
  - 4.2.2.1. Overview
  - 4.2.2.2. Product Portfolio
  - 4.2.2.3. Financial Analysis
  - 4.2.2.4. SWOT Analysis
  - 4.2.2.5. Business Strategy
- 4.2.3. Masimo Corporation
  - 4.2.3.1. Overview
  - 4.2.3.2. Product Portfolio
  - 4.2.3.3. Financial Analysis
  - 4.2.3.4. SWOT Analysis
  - 4.2.3.5. Business Strategy
- 4.2.4. Medtronic plc
  - 4.2.4.1. Overview
  - 4.2.4.2. Product Portfolio
  - 4.2.4.3. Financial Analysis
  - 4.2.4.4. SWOT Analysis
  - 4.2.4.5. Business Strategy
- 4.2.5. Nihon Kohden Corporation
  - 4.2.5.1. Overview
  - 4.2.5.2. Product Portfolio
  - 4.2.5.3. Financial Analysis
  - 4.2.5.4. SWOT Analysis
  - 4.2.5.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration

5. US Capnography Devices Market Sales Analysis by Product Type ($ Million)

5.1. Handheld
5.2. Standalone
5.3. Multiparameter
5.4. Others

6. US Capnography Devices Market Sales Analysis by Application ($ Million)

6.1. Respiratory Disease
6.2. Cardiology
6.3. Trauma & Emergency
6.4. Others

7. US Capnography Devices Market Sales Analysis by End-User ($ Million)

7.1. Hospital & Clinics
7.2. Ambulatory Surgical Centers

8. Company Profiles

8.1. Ambu A/S
- 8.1.1. Quick Facts
- 8.1.2. Company Overview
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategies
8.2. Avante Health Solutions
- 8.2.1. Quick Facts
- 8.2.2. Company Overview
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategies
8.3. Becton, Dickinson and Company
- 8.3.1. Quick Facts
- 8.3.2. Company Overview
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategies
8.4. Criticare Technologies, Inc.
- 8.4.1. Quick Facts
- 8.4.2. Company Overview
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategies
8.5. Diamedica Ltd.
- 8.5.1. Quick Facts
- 8.5.2. Company Overview
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategies
8.6. Dragerwerk AG & Co. KGaA
- 8.6.1. Quick Facts
- 8.6.2. Company Overview
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategies
8.7. Edan USA
- 8.7.1. Quick Facts
- 8.7.2. Company Overview
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategies
8.8. GE HealthCare Technologies Inc.
- 8.8.1. Quick Facts
- 8.8.2. Company Overview
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategies
8.9. Hill Rom Holdings, Inc.
- 8.9.1. Quick Facts
- 8.9.2. Company Overview
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategies
8.10. ICU Medical, Inc.
- 8.10.1. Quick Facts
- 8.10.2. Company Overview
- 8.10.3. Product Portfolio
- 8.10.4. Business Strategies
8.11. Infinium Medical, Inc.
- 8.11.1. Quick Facts
- 8.11.2. Company Overview
- 8.11.3. Product Portfolio
- 8.11.4. Business Strategies
8.12. Koninklijke Philips N.V.
- 8.12.1. Quick Facts
- 8.12.2. Company Overview
- 8.12.3. Product Portfolio
- 8.12.4. Business Strategies
8.13. Masimo Corporation
- 8.13.1. Quick Facts
- 8.13.2. Company Overview
- 8.13.3. Product Portfolio
- 8.13.4. Business Strategies
8.14. Medtronic plc
- 8.14.1. Quick Facts
- 8.14.2. Company Overview
- 8.14.3. Product Portfolio
- 8.14.4. Business Strategies
8.15. Mindray Medical International Limited
- 8.15.1. Quick Facts
- 8.15.2. Company Overview
- 8.15.3. Product Portfolio
- 8.15.4. Business Strategies
8.16. Nihon Kohden Corporation
- 8.16.1. Quick Facts
- 8.16.2. Company Overview
- 8.16.3. Product Portfolio
- 8.16.4. Business Strategies
8.17. Nonin Medical, Inc.
- 8.17.1. Quick Facts
- 8.17.2. Company Overview
- 8.17.3. Product Portfolio
- 8.17.4. Business Strategies
8.18. Smiths Medical
- 8.18.1. Quick Facts
- 8.18.2. Company Overview
- 8.18.3. Product Portfolio
- 8.18.4. Business Strategies
8.19. Spacelabs Healthcare
- 8.19.1. Quick Facts
- 8.19.2. Company Overview
- 8.19.3. Product Portfolio
- 8.19.4. Business Strategies
8.20. ZOLL Medical Corporation
- 8.20.1. Quick Facts
- 8.20.2. Company Overview
- 8.20.3. Product Portfolio
- 8.20.4. Business Strategies